Atlas Trials

Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia

Clinical trial NCT00268242 · TERMINATED

Trial details

NCT number
NCT00268242
Sponsor
The Cleveland Clinic
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2006-01-01
Primary completion
2010-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.